Also found in: Dictionary, Thesaurus, Wikipedia.
Related to Celebrex: Tramadol
Pharmacologic class: Nonsteroidal cyclooxygenase-2 (COX-2) inhibitor, nonsteroidal anti-inflammatory drug (NSAID)
Therapeutic class: Antirheumatic
Pregnancy risk category C
FDA Box Warning
• Drug may increase risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke (which can be fatal). Risk may increase with duration of use, and may be greater in patients who have cardiovascular disease or risk factors for it.
• Drug is contraindicated for perioperative pain in setting of coronary artery bypass graft surgery.
• Drug increases risk of serious GI adverse events, including bleeding, ulcers, and stomach or intestinal perforation, which can be fatal. These events can occur at any time during therapy and without warning. Elderly patients are at greater risk.
Exhibits anti-inflammatory, analgesic, and antipyretic action due to inhibition of COX-2 enzyme
Capsules: 50 mg, 100 mg, 200 mg, 400 mg
⊘Indications and dosages
➣ Ankylosing spondylitis, osteoarthritis
Adults: 200 mg/day P.O. as a single dose or 100 mg P.O. b.i.d.
➣ Rheumatoid arthritis
Adults: 100 to 200 mg P.O. b.i.d.
➣ Adjunctive treatment in familial adenomatous polyposis to decrease the number of adenomatous colorectal polyps
Adults: 400 mg P.O. b.i.d.
➣ Acute pain or primary dysmenorrhea
Adults: 400 mg P.O. once, plus one additional 200 mg-dose as needed on first day; then 200 mg b.i.d. as needed
➣ Juvenile rheumatoid arthritis
Children age 2 and older weighing 10 to 25 kg (22 to 55 lb): 50 mg P.O. b.i.d.
Children age 2 and older weighing 25 kg or more: 100 mg P.O. b.i.d.
• Hepatic impairment
• Patients weighing less than 50 kg (110 lb)
• Hypersensitivity to drug, sulfonamides, or other NSAIDs
• Advanced renal disease
• Severe hepatic impairment
• Sensitivity precipitated by aspirin
• Third trimester of pregnancy
Use cautiously in:
• renal insufficiency, hypertension
• history of asthma, urticaria, renal disease, hepatic dysfunction, heart failure
• patients on long-term NSAID therapy
• elderly patients
• pregnant patients in first or second trimester
• children younger than age 18 (safety not established).
• When administering doses higher than 200/mg daily, give with food or milk to improve drug absorption.
CNS: dizziness, drowsiness, headache, insomnia, fatigue, stroke
CV: angina, tachycardia, peripheral edema, myocardial infarction
EENT: ophthalmic effects, tinnitus, epistaxis, pharyngitis, rhinitis, sinusitis
GI: nausea, diarrhea, constipation, abdominal pain, dyspepsia, flatulence, dry mouth, GI bleeding
GU: menorrhagia, renal failure
Hematologic: eosinophilia, ecchymosis, neutropenia, leukopenia, pancytopenia, thrombocytopenia, agranulocytosis, granulocytopenia, aplastic anemia, bone marrow depression
Metabolic: hyperchloremia, hypophosphatemia
Musculoskeletal: back pain, leg cramps
Respiratory: upper respiratory tract infection
Drug-drug.Angiotensin-converting enzyme inhibitors, furosemide, thiazides: reduced celecoxib efficacy
Antacids containing aluminum and magnesium: decreased celecoxib blood level
Aspirin (regular doses): increased risk of GI bleeding and GI ulcers
Fluconazole, lithium: increased blood levels of these drugs
Warfarin: increased risk of bleeding
Drug-diagnostic tests.Alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen: increased levels
Hematocrit, hemoglobin: decreased values
Drug-herbs.Dong quai, feverfew, garlic, ginger, horse chestnut, red clover: increased risk of bleeding
White willow: increased risk of GI ulcers
Drug-behaviors.Long-term alcohol use, smoking: GI irritation and bleeding
• Monitor CBC, electrolyte levels, creatinine clearance, occult fecal blood test, and liver function test results every 6 to 12 months.
Advise patient to immediately report bloody stools, vomiting of blood, or signs or symptoms of liver damage (nausea, fatigue, lethargy, pruritus, yellowing of eyes or skin, tenderness in upper right abdomen, or flulike symptoms).
• Instruct patient to take drug with food or milk.
• Tell patient to avoid aspirin and other NSAIDs (such as ibuprofen and naproxen) during therapy.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, herbs, and behaviors mentioned above.
Pharmacologic: cox 2 inhibitors
Time/action profile (pain reduction)
|PO||24–48 hr||unknown||12–24 hr†|
Adverse Reactions/Side Effects
Central nervous system
- myocardial infarction (life-threatening)
- stroke (life-threatening)
- thrombosis (life-threatening)
- gi bleeding (life-threatening)
- abdominal pain
- exfoliative dermatitis (life-threatening)
- stevens-johnson syndrome (life-threatening)
- toxic epidermal necrolysis (life-threatening)
Drug-Drug interactionCYP2C9 inhibitors may ↑ levels.May ↓ effectiveness of ACE inhibitors, thiazide diuretics, and furosemide.Fluconazole ↑ levels (use lowest recommended dosage).May ↑ risk of bleeding with warfarin and aspirin.May ↑ serum lithium levels.Does not inhibit the cardioprotective effect of low-dose aspirin.
Hepatic ImpairmentOral (Adults) Moderate hepatic impairment (Child-Pugh Class B)—↓ dose by 50%.
- Assess range of motion, degree of swelling, and pain in affected joints before and periodically throughout therapy.
- Assess patient for allergy to sulfonamides, aspirin, or NSAIDs. Patients with these allergies should not receive celecoxib.
- Assess patient for skin rash frequently during therapy. Discontinue at first sign of rash; may be life-threatening. Stevens-Johnson syndrome may develop. Treat symptomatically; may recur once treatment is stopped.
- Lab Test Considerations: May cause ↑ AST and ALT levels.
- May cause hypophosphatemia and ↑ BUN.
Potential Nursing DiagnosesImpaired physical mobility (Indications)
Acute pain (Indications)
- Do not confuse with Celexa (citalopram) or Cerebyx (fosphenytoin).
- Oral: May be administered without regard to meals. Capsules may be opened and sprinkled on applesauce and ingested immediately with water. Mixture may be stored in the refrigerator for up to 6 hr.
- Instruct patient to take celecoxib exactly as directed. Do not take more than prescribed dose. Increasing doses does not appear to increase effectiveness. Use lowest effective dose for shortest period of time.
- Advise patient to notify health care professional promptly if signs or symptoms of GI toxicity (abdominal pain, black stools), skin rash, unexplained weight gain, edema, or chest pain occurs. Patients should discontinue celecoxib and notify health care professional if signs and symptoms of hepatotoxicity (nausea, fatigue, lethargy, pruritus, jaundice, upper right quadrant tenderness, flu-like symptoms) occur.
- Advise patient to notify health care professional if pregnancy is planned or suspected.
- Reduction in joint pain in patients with osteoarthritis.
- Reduction in joint tenderness, pain, and joint swelling in patients with rheumatoid arthritis and juvenile rheumatoid arthritis.
- Decreased pain with dysmenorrhea.